Patricia L Allen
CIK 1348587 · Chief Financial Officer · last filed 2026-02-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$7.79M
Companies
5
Total Filings
31
Lifetime Open-Market Net
-$2.88M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ZBIO | Director | 19,860 | $19.80 | $393.2K | $499.7K | 3 | 2026-02-13 |
| Deciphera Pharmaceuticals, Inc. (DCPH) Delisted | Director | 0 | $25.59 | $0 | -$2.34M | 13 | 2024-06-11 |
| KINETA, INC./DE (YMTX) Delisted | Director | — | $13.23 | — | $0 | 2 | 2021-06-04 |
| Larimar Therapeutics, Inc. (ZFGN) Delisted | Chief Financial Officer | 19,793 | — | — | $49.9K | 6 | 2019-01-24 |
| ALNY | VP of Finance and Treasurer | 26,165 | $282.85 | $7.40M | -$1.08M | 7 | 2010-12-10 |
Recent Filings · Page 4 of 4
31 filingsForm 4 transactions across all companies, newest first.
Showing 31–31 of 31
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.